




Searching News Database: nanoparticle
HSMN NewsFeed - 26 Nov 2024
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
HSMN NewsFeed - 17 Nov 2023
Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic Priorities
Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic Priorities
HSMN NewsFeed - 19 Jun 2023
Sirnaomics Advances STP705 for Squamous Cell Carcinoma In Situ into Late-Stage Clinical Development
Sirnaomics Advances STP705 for Squamous Cell Carcinoma In Situ into Late-Stage Clinical Development
HSMN NewsFeed - 28 Jun 2022
Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing
Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing
HSMN NewsFeed - 23 Mar 2021
Poseida Therapeutics Announces Carl June, M.D., to Chair Immuno-Oncology Scientific Advisory Board
Poseida Therapeutics Announces Carl June, M.D., to Chair Immuno-Oncology Scientific Advisory Board
HSMN NewsFeed - 25 Mar 2020
Elevar Therapeutics Acquires Global Rights to European Approved Apealea(R) from Oasmia Pharmaceutical
Elevar Therapeutics Acquires Global Rights to European Approved Apealea(R) from Oasmia Pharmaceutical
HSMN NewsFeed - 14 Oct 2019
Magnetic Insight Announces the Appointment of David Panzarella as Chief Commercial Officer
Magnetic Insight Announces the Appointment of David Panzarella as Chief Commercial Officer
HSMN NewsFeed - 25 Sep 2018
Dr. Dmitry Samarsky Joins Sirnaomics Senior Management Team as Chief Technology Officer
Dr. Dmitry Samarsky Joins Sirnaomics Senior Management Team as Chief Technology Officer
HSMN NewsFeed - 13 Dec 2016
Creative Medical Technology Holdings Files Patent on AmnioStem Stroke Therapy
Creative Medical Technology Holdings Files Patent on AmnioStem Stroke Therapy
HSMN NewsFeed - 24 Aug 2015
Celator(R) Pharmaceuticals Appoints Michael R. Dougherty as Executive Chairman of Board of Directors
Celator(R) Pharmaceuticals Appoints Michael R. Dougherty as Executive Chairman of Board of Directors
HSMN NewsFeed - 20 Apr 2015
Oasmia's Lead Cancer Product Paclical(R) Receives Market Approval in the Russian Federation
Oasmia's Lead Cancer Product Paclical(R) Receives Market Approval in the Russian Federation
HSMN NewsFeed - 18 Mar 2015
Hong Kong Authority Approves Abraxane(R) as First-Line Treatment For Late-Stage Pancreatic Cancer
Hong Kong Authority Approves Abraxane(R) as First-Line Treatment For Late-Stage Pancreatic Cancer
HSMN NewsFeed - 3 Sep 2014
Celator(R) Pharmaceuticals Announces Appointment of Michael Dougherty as Chairman of the Board
Celator(R) Pharmaceuticals Announces Appointment of Michael Dougherty as Chairman of the Board
HSMN NewsFeed - 5 May 2014
Immune Pharmaceuticals Announces Phase 3 Development and Commercialization Strategy for AMIKET
Immune Pharmaceuticals Announces Phase 3 Development and Commercialization Strategy for AMIKET
HSMN NewsFeed - 19 Dec 2013
Celator(R) Pharmaceuticals Appoints Joseph M. Lobacki to Board of Directors
Celator(R) Pharmaceuticals Appoints Joseph M. Lobacki to Board of Directors
HSMN NewsFeed - 14 Nov 2013
Sorrento Enters into Definitive Agreement to Acquire Antibody Drug Conjugation Technology
Sorrento Enters into Definitive Agreement to Acquire Antibody Drug Conjugation Technology
HSMN NewsFeed - 28 Oct 2013
Arcturus Therapeutics Appoints Zachary A. Zimmerman, Ph.D., as Chief Business Officer
Arcturus Therapeutics Appoints Zachary A. Zimmerman, Ph.D., as Chief Business Officer
HSMN NewsFeed - 20 Aug 2013
EpiCept Announces Reverse Stock Split and Change of Corporate Name to Immune Pharmaceuticals Inc.
EpiCept Announces Reverse Stock Split and Change of Corporate Name to Immune Pharmaceuticals Inc.
HSMN NewsFeed - 12 Aug 2013
Tekmira Strengthens Development Team With Appointment of Dr. Mark Kowalski as Chief Medical Officer
Tekmira Strengthens Development Team With Appointment of Dr. Mark Kowalski as Chief Medical Officer
HSMN NewsFeed - 24 Jul 2013
Celator(R) Pharmaceuticals Appoints Michael R. Dougherty to Board of Directors
Celator(R) Pharmaceuticals Appoints Michael R. Dougherty to Board of Directors
HSMN NewsFeed - 7 Jan 2013
Celator(R) Pharmaceuticals Announces Appointment of Lisa DeLuca as Vice President, Regulatory Affairs
Celator(R) Pharmaceuticals Announces Appointment of Lisa DeLuca as Vice President, Regulatory Affairs
HSMN NewsFeed - 19 Dec 2012
Sirnaomics Advances Its Novel siRNA Therapeutics Against HPV Infection and Cervical Cancer
Sirnaomics Advances Its Novel siRNA Therapeutics Against HPV Infection and Cervical Cancer
HSMN NewsFeed - 18 Dec 2012
Celator(R) Pharmaceuticals Announces Appointment of Fred Powell as Chief Financial Officer
Celator(R) Pharmaceuticals Announces Appointment of Fred Powell as Chief Financial Officer
HSMN NewsFeed - 27 Nov 2012
Regulus Appoints Victor Knopov, Ph.D. as Vice President, Pharmaceutical Development
Regulus Appoints Victor Knopov, Ph.D. as Vice President, Pharmaceutical Development
HSMN NewsFeed - 22 May 2012
MagForce signs distribution agreement with leading Russian medical device distribution company DELRUS
MagForce signs distribution agreement with leading Russian medical device distribution company DELRUS
HSMN NewsFeed - 26 Mar 2012
MagForce AG Announces Company Restructuring and Revised Corporate Strategy for 2012
MagForce AG Announces Company Restructuring and Revised Corporate Strategy for 2012
HSMN NewsFeed - 10 Oct 2011
MagForce AG Announces Treatment of Recurrent Glioblastoma Patient with NanoTherm(R) Therapy
MagForce AG Announces Treatment of Recurrent Glioblastoma Patient with NanoTherm(R) Therapy
HSMN NewsFeed - 20 Sep 2011
SurModics IVD Introduces A New BioFX(R) TMB Enhanced HRP Membrane Substrate
SurModics IVD Introduces A New BioFX(R) TMB Enhanced HRP Membrane Substrate
HSMN NewsFeed - 31 Aug 2011
Selecta Biosciences Appoints Takashi Kei Kishimoto, Ph.D., as Chief Scientific Officer
Selecta Biosciences Appoints Takashi Kei Kishimoto, Ph.D., as Chief Scientific Officer
HSMN NewsFeed - 29 Jun 2011
Tekmira Reports Expected Answer and Amended Counterclaim is Filed by Alnylam
Tekmira Reports Expected Answer and Amended Counterclaim is Filed by Alnylam
HSMN NewsFeed - 7 Feb 2011
CPAC Announces Major Milestone in Development of Compact Proton Therapy Solution
CPAC Announces Major Milestone in Development of Compact Proton Therapy Solution
HSMN NewsFeed - 15 Oct 2010
SurModics Announces Organizational Changes to Reduce Cost Structure and Renew Focus on Business Units
SurModics Announces Organizational Changes to Reduce Cost Structure and Renew Focus on Business Units
HSMN NewsFeed - 16 Aug 2010
Selecta Biosciences Appoints Werner Cautreels, Ph.D., as Company's First CEO
Selecta Biosciences Appoints Werner Cautreels, Ph.D., as Company's First CEO
HSMN NewsFeed - 21 Apr 2010
Manhattan Scientifics' Technology Able to Detect Breast Cancer Three Years Earlier Than Mammogram
Manhattan Scientifics' Technology Able to Detect Breast Cancer Three Years Earlier Than Mammogram
HSMN NewsFeed - 28 Jan 2010
Abraxis BioScience Confirms Plan to Spin-off Abraxis Health in 2010 and Announces Management Structure
Abraxis BioScience Confirms Plan to Spin-off Abraxis Health in 2010 and Announces Management Structure
HSMN NewsFeed - 16 Dec 2009
Savara Closes Second Tranche of Series A Financing Round, Receives Allowance for Base Patent
Savara Closes Second Tranche of Series A Financing Round, Receives Allowance for Base Patent
HSMN NewsFeed - 24 Nov 2009
MDRNA Expands RNAi Bladder Cancer Program With the Vancouver Prostate Centre
MDRNA Expands RNAi Bladder Cancer Program With the Vancouver Prostate Centre
HSMN NewsFeed - 5 Nov 2009
ABRAXANE(R) Receives Orphan Drug Status for the Treatment of Pancreatic Cancer and Stage IIB-IV Melanoma
ABRAXANE(R) Receives Orphan Drug Status for the Treatment of Pancreatic Cancer and Stage IIB-IV Melanoma
HSMN NewsFeed - 6 Oct 2009
SurModics Enters Ophthalmic License and Development Agreement with Roche and Genentech
SurModics Enters Ophthalmic License and Development Agreement with Roche and Genentech
HSMN NewsFeed - 8 Apr 2009
Cerulean Pharma Inc. Announces Appointment of Oliver S. Fetzer as President and Chief Executive Officer
Cerulean Pharma Inc. Announces Appointment of Oliver S. Fetzer as President and Chief Executive Officer
HSMN NewsFeed - 12 Mar 2009
I-Flow Corporation Receives FDA Clearance for Stabilized Antimicrobial Wound Gel
I-Flow Corporation Receives FDA Clearance for Stabilized Antimicrobial Wound Gel
HSMN NewsFeed - 27 Jan 2009
SurModics and Nexeon MedSystems to Collaborate on Development of Novel Stent System for Renal Artery Disease
SurModics and Nexeon MedSystems to Collaborate on Development of Novel Stent System for Renal Artery Disease
HSMN NewsFeed - 25 Sep 2008
Acusphere, Inc. Appoints Michael Slater SVP Regulatory Affairs and Operations Replacing Dennis Bucceri
Acusphere, Inc. Appoints Michael Slater SVP Regulatory Affairs and Operations Replacing Dennis Bucceri
HSMN NewsFeed - 24 Sep 2008
I-Flow Corporation Receives 510(k) Clearance From FDA for Oxygenated Topical Dressing
I-Flow Corporation Receives 510(k) Clearance From FDA for Oxygenated Topical Dressing
HSMN NewsFeed - 16 Jul 2008
BioAlliance Pharma suspends the Phase II/III trial of doxorubicin Transdrug(R) in primary liver cancer
BioAlliance Pharma suspends the Phase II/III trial of doxorubicin Transdrug(R) in primary liver cancer
HSMN NewsFeed - 30 Jun 2008
Acusphere Announces FDA Acceptance of Imagify(TM) NDA for Detection of Coronary Artery Disease
Acusphere Announces FDA Acceptance of Imagify(TM) NDA for Detection of Coronary Artery Disease
HSMN NewsFeed - 23 Jun 2008
BioAlliance Pharma extends its Loramyc(TM) License to China with NovaMed Pharmaceuticals
BioAlliance Pharma extends its Loramyc(TM) License to China with NovaMed Pharmaceuticals
HSMN NewsFeed - 2 Jun 2008
Tekmira Pharmaceuticals and Protiva Biotherapeutics Announce Completion of Business Combination
Tekmira Pharmaceuticals and Protiva Biotherapeutics Announce Completion of Business Combination
HSMN NewsFeed - 9 Apr 2008
Abraxis BioScience Announces Approval to Market ABRAXANE for Metastatic Breast Cancer in Korea
Abraxis BioScience Announces Approval to Market ABRAXANE for Metastatic Breast Cancer in Korea
HSMN NewsFeed - 31 Mar 2008
Acusphere Licenses Hydrophobic Drug Delivery System to Cephalon for $10 Million
Acusphere Licenses Hydrophobic Drug Delivery System to Cephalon for $10 Million
HSMN NewsFeed - 26 Mar 2008
BioAlliance Pharma Receives Market Approval for Loramyc(R) in Germany, Belgium and Luxemburg
BioAlliance Pharma Receives Market Approval for Loramyc(R) in Germany, Belgium and Luxemburg
HSMN NewsFeed - 11 Mar 2008
I-Flow Leads Infection Prevention Trend by Using Silver with Antimicrobial Properties in Medical Devices
I-Flow Leads Infection Prevention Trend by Using Silver with Antimicrobial Properties in Medical Devices
HSMN NewsFeed - 19 Feb 2008
Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
HSMN NewsFeed - 22 Jan 2008
Abraxis Receives Approval from EU Commission to Market ABRAXANE for Metastatic Breast Cancer in Europe
Abraxis Receives Approval from EU Commission to Market ABRAXANE for Metastatic Breast Cancer in Europe
HSMN NewsFeed - 9 Jan 2008
BioAlliance Pharma Receives Market Approval for Loramyc(R) in the United Kingdom and Denmark
BioAlliance Pharma Receives Market Approval for Loramyc(R) in the United Kingdom and Denmark
HSMN NewsFeed - 25 Sep 2007
ULURU Inc. Announces the Appointment of Renaat Van den Hooff to Join Executive Team
ULURU Inc. Announces the Appointment of Renaat Van den Hooff to Join Executive Team
HSMN NewsFeed - 24 Jul 2007
Advanced Magnetics, Inc. Announces Name Change to AMAG Pharmaceuticals, Inc.
Advanced Magnetics, Inc. Announces Name Change to AMAG Pharmaceuticals, Inc.
HSMN NewsFeed - 7 Jun 2007
Patrick Gallagher Joins Acusphere as Senior Vice President, Business Development
Patrick Gallagher Joins Acusphere as Senior Vice President, Business Development
HSMN NewsFeed - 1 May 2007
Acusphere Announces Positive Results from Pivotal Phase 3 Clinical Trial of Imagify(TM)
Acusphere Announces Positive Results from Pivotal Phase 3 Clinical Trial of Imagify(TM)
HSMN NewsFeed - 9 Apr 2007
Advanced Magnetics Announces Appointment of Kristen P. Galfetti as Senior Director Investor Relations
Advanced Magnetics Announces Appointment of Kristen P. Galfetti as Senior Director Investor Relations
HSMN NewsFeed - 15 Feb 2007
Advanced Magnetics Announces Settlement of Lawsuit with Cytogen Corporation
Advanced Magnetics Announces Settlement of Lawsuit with Cytogen Corporation
HSMN NewsFeed - 11 Dec 2006
Abraxis BioScience to Present Data from Six Studies at San Antonio Breast Cancer Symposium
Abraxis BioScience to Present Data from Six Studies at San Antonio Breast Cancer Symposium
HSMN NewsFeed - 19 Oct 2006
PharmaNova Grants Exclusive U.S. License to Depomed for Extended Release Gabapentin Use in Hot Flashes
PharmaNova Grants Exclusive U.S. License to Depomed for Extended Release Gabapentin Use in Hot Flashes
HSMN NewsFeed - 13 Oct 2006
BioAlliance Pharma Receives Marketing Authorisation for Its First Product, Loramyc(R)
BioAlliance Pharma Receives Marketing Authorisation for Its First Product, Loramyc(R)
HSMN NewsFeed - 29 Sep 2006
Published Data Show Kereos Technology Specifically Targets Arterial Plaque
Published Data Show Kereos Technology Specifically Targets Arterial Plaque
HSMN NewsFeed - 20 Sep 2006
Acusphere Hires Jonathan Jaffe, M.D. in Newly Created Position of Vice President Medical Affairs
Acusphere Hires Jonathan Jaffe, M.D. in Newly Created Position of Vice President Medical Affairs
HSMN NewsFeed - 17 Jul 2006
BioAlliance Pharma Strengthens International Capabilities in Key Legal, IP and Regulatory Departments
BioAlliance Pharma Strengthens International Capabilities in Key Legal, IP and Regulatory Departments
HSMN NewsFeed - 26 Jun 2006
BioAlliance Pharma Strengthens Operational Management Ahead of Loramyc(R) Launch
BioAlliance Pharma Strengthens Operational Management Ahead of Loramyc(R) Launch
HSMN NewsFeed - 19 May 2006
Novavax and Esprit Pharma to Co-develop Novel Medicine for Female Sexual Desire Disorder
Novavax and Esprit Pharma to Co-develop Novel Medicine for Female Sexual Desire Disorder
HSMN NewsFeed - 16 May 2006
BioAlliance Pharma Boosts Business Development Operations in Europe and US
BioAlliance Pharma Boosts Business Development Operations in Europe and US
Additional items found! 138

Members Archive contains
138 additional stories matching:
nanoparticle
(Password required)
nanoparticle
(Password required)